The prognostic impact of neoadjuvant chemoradiotherapy on lymph node sampling in patients with locally advanced rectal cancer
- PMID: 32632764
- PMCID: PMC7481149
- DOI: 10.1007/s13304-020-00841-3
The prognostic impact of neoadjuvant chemoradiotherapy on lymph node sampling in patients with locally advanced rectal cancer
Abstract
According to the American Joint Committee on Cancer, at least 12 lymph nodes are required to accurately stage locally advanced rectal cancer (LARC). Neoadjuvant chemoradiation therapy (NACRT) reduces the number of lymph nodes retrieved during surgery. In this study, we evaluated the effect of NACRT on lymph node retrieval and prognosis in patients with LARC. We performed an observational study of 142 patients with LARC. Although our analysis was retrospective, data were collected prospectively. Half the patients were treated with NACRT and total mesorectal excision (TME) and the other half underwent TME only. The number of lymph nodes retrieved and the number of metastatic lymph nodes were significantly reduced in the NACRT group (P > 0.001). In the univariate and multivariate analyses, only NACRT and patient age were significantly associated with reduced lymph node retrieval. The number of metastatic lymph nodes and the lymph node ratio (LNR) both had a significant effect on prognosis when the patient population was examined as a whole (P = 0.003 and P = 0.001, respectively). However, the LNR was the only significant, independent prognostic factor in both treatment groups (P = 0.007 for the NACRT group; P = 0.04 for the no-NACRT group). NACRT improves patient prognosis only when the number of metastatic lymph nodes is reduced. The number of metastatic lymph nodes and the LNR are important prognostic factors. Lymph node retrieval remains an indispensable tool for staging and prognostic assessment of patients with rectal carcinoma treated with NACRT.
Keywords: Lymph node ratio; Lymph node sampling; Neoadjuvant chemoradiotherapy; Rectal cancer.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.Medicine (Baltimore). 2016 Mar;95(9):e2988. doi: 10.1097/MD.0000000000002988. Medicine (Baltimore). 2016. PMID: 26945418 Free PMC article.
-
Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.Surgery. 2019 Dec;166(6):1061-1067. doi: 10.1016/j.surg.2019.06.009. Epub 2019 Jul 23. Surgery. 2019. PMID: 31345564
-
Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.Asian Pac J Cancer Prev. 2014;15(13):5365-9. doi: 10.7314/apjcp.2014.15.13.5365. Asian Pac J Cancer Prev. 2014. PMID: 25041003
-
The effects of preoperative chemoradiotherapy on lymph node sampling in rectal cancer.Dis Colon Rectum. 2012 Sep;55(9):1002-7. doi: 10.1097/DCR.0b013e3182536d70. Dis Colon Rectum. 2012. PMID: 22874609 Review.
-
Using a Lymph Node Count Metric to Identify Underperforming Hospitals After Rectal Cancer Surgery.J Surg Res. 2019 Apr;236:216-223. doi: 10.1016/j.jss.2018.11.040. Epub 2018 Dec 20. J Surg Res. 2019. PMID: 30694758 Review.
Cited by
-
Epigenetic Aging and Colorectal Cancer: State of the Art and Perspectives for Future Research.Int J Mol Sci. 2020 Dec 28;22(1):200. doi: 10.3390/ijms22010200. Int J Mol Sci. 2020. PMID: 33379143 Free PMC article. Review.
-
Risk score model for predicting local control and survival in patients with rectal cancer treated with neoadjuvant chemoradiotherapy.Oncol Lett. 2025 Mar 26;29(5):249. doi: 10.3892/ol.2025.14995. eCollection 2025 May. Oncol Lett. 2025. PMID: 40177134 Free PMC article.
-
Log odds of positive nodes as a prognostic factor for rectal cancer: a retrospective study.Rev Assoc Med Bras (1992). 2024 Jan 5;70(2):e20230417. doi: 10.1590/1806-9282.2023417. eCollection 2024. Rev Assoc Med Bras (1992). 2024. PMID: 38198298 Free PMC article.
-
Prognosis and influencing factors of patients with different lymph node statuses after pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer.Oncol Lett. 2025 May 22;30(1):359. doi: 10.3892/ol.2025.15105. eCollection 2025 Jul. Oncol Lett. 2025. PMID: 40463356 Free PMC article.
-
Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy.World J Gastroenterol. 2020 Nov 14;26(42):6638-6657. doi: 10.3748/wjg.v26.i42.6638. World J Gastroenterol. 2020. PMID: 33268952 Free PMC article.
References
-
- Scarinci A, Di Cesare T, Cavaniglia D, Neri T, Colletti M, Cosenza G, Liverani A. The impact of log odds of positive lymph nodes (LODDS) in colon and rectal cancer patient stratification: a single-center analysis of 323 patients. Updates Surg. 2018;70:23–31. doi: 10.1007/s13304-018-0519-3. - DOI - PMC - PubMed
-
- Bustamante-Lopez L, Nahas CS, Nahas SC, Ribeiro U, Jr, Marques CF, Cotti G, Rocco A, Cecconello I. Understanding the factors associated with reduction in the number of lymph nodes in rectal cancer patients treated by neoadjuvant treatment. Int J Colorectal Dis. 2017;32:925–927. doi: 10.1007/s00384-016-2747-7. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources